Recruiting

Observational Study

Sponsor:

University of Colorado, Denver

Code:

NCT07288476

Conditions

Pediatric Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

educational video

Study Details

Brief summary:

Families of children with cancer who speak languages other than English experience inequalities in healthcare, but little research has been done on solutions to improve care for these families. This study will partner parents with medical interpreters and clinicians to create educational videos about key cancer topics in Spanish and test their use as a tool to improve caregiver knowledge and experience in the setting of a language barrier. The project will lead to a future career development award application that increases the number of available languages and studies how multilingual educational videos impact caregiver knowledge and experience

Conditions

Pediatric Cancer

Study ID

NCT07288476

Start date

Jul 2, 2025

Status verified date

Feb, 2026

Completion date

Dec, 2027

Anticipated

Primary completion date

Dec, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

Aims 1 and 2 (Video Development Phase):

  • Legal caregiver aged ≥18 years of a child/young adult (0-25 years) undergoing active cancer treatment in low-intensity phases or off therapy.
  • Native or fluent Spanish speaker.
  • Willing and able to provide verbal consent.
  • Willing to comply with study procedures and be available for the study duration.

Aim 3 (Video Pilot Phase):

  • Legal caregiver aged ≥18 years of a child/young adult (0-25 years) with newly diagnosed or relapsed/refractory cancer (≤1 month).N
  • Native or fluent Spanish speaker.
  • Requires an interpreter for medical conversations.
  • Willing and able to provide verbal consent.
  • Willing to comply with study procedures and be available for the study duration.

Exclusion Criteria:

Aims 1 and 2:

  • Insufficient cognitive functioning to complete study procedures (as determined by PI).
  • Caregiver of a child/young adult who did not receive cancer-directed therapy.
  • Caregiver of a child/young adult receiving high-intensity cancer treatment.
  • Unable to read and speak Spanish fluently.

Aim 3:

  • Insufficient cognitive functioning to complete study measures (as determined by PI).Caregiver of a child/young adult who did not receive cancer-directed therapy.
  • Caregiver of a child/young adult not receiving cancer-directed therapy.
  • Diagnosis of new or relapsed/refractory cancer occurred >1 month prior to enrollment.
  • Unable to speak Spanish fluently.
  • Does not require an interpreter for medical conversations.

Study Design

Enrollment

10 participants

Anticipated

Intervention Model

Single group

Primary purpose

Supportive Care

Interventions and Outcome Measures

Arms

experimental: Pilot educational videos

Pilot education videos with Spanish-speaking parents as a tool to improve caregiver knowledge, satisfaction, confidence in caring for their child, and level of overwhelm.

Interventions

educational video

Spanish-language video to impart knowledge and understanding to parents caring for children with cancer

Primary outcome measure

  • Feasibility of Implementing a Spanish-Language Educational Video Intervention [ Time Frame: 6 months ]
  • Acceptability of Implementing a Spanish-Language Educational Video Intervention [ Time Frame: 6 months ]

Central Contacts and Locations

Central contacts

Melanie Stall, MD

720-777-1234melanie.stall@childrenscolorado.org

Locations

Children's Hospital Colorado

Recruiting

Aurora, Colorado, United States, 80045

Contacts

Glenn Buck

720-777-3442glenn.buck@childrenscolorado.org

Principal Investigator:

Melanie Stall, MD

More Information

Sponsor

University of Colorado, Denver

Last update posted

Feb 13, 2026

Last verified

Feb, 2026

Keywords

  • Spanish Speaking

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Colorado, Denver on 2026-02-13.